BOULDER, Colo., Jan. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)



    Event:                   Annual J.P. Morgan Healthcare Conference

    Presenter:                Ron Squarer, Chief Executive Officer, Array
                              BioPharma

    Date:                    Tuesday, January 14, 2014

    Time:                    4:00 p.m. Pacific Time

    Location:                Westin St. Francis Hotel, San Francisco

    Webcast:                 www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis). For more information on Array, please go to www.arraybiopharma.com



    CONTACT:                Tricia Haugeto

                            Array BioPharma Inc.

                            303-386-1193

                            thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.